Posted by Michael Wonder on 28 Apr 2018
CAR-T therapy could be available to NHS patients this year
27 April 2018 - NHS England chief executive Simon Stevens has indicated that chimeric antigen receptor T-cell therapy (CAR-T) could be available on the NHS this year, offering eligible patients a ‘ground-breaking’ approach to treating cancer.
Addressing the Association of the British Pharmaceutical Industry’s annual conference in London, he said “preparations are underway to make CAR-T, one of the most innovative treatments that has ever been offered on the NHS available to patients.”
But he also stressed manufacturers “need to set fair and affordable prices so treatments can be made available to all who need them.”
